tirzepatide discontinuation weight regain study Monthly GLP-1 for Maintenance Two Years After Stopping GLP-1s,
Description
Despite our knowledge of obesity as a treatable, chronic disease, people living with obesity still face many challenges in their health and weight management journey, said Joe Nadglowski, president and chief executive officer of the Obesity Action Coalition

While some patients report anxiety on tirzepatide , it is far less common and typically related to the adjustment period rather than a direct pharmacological effect

This difference is also reflected in the percentage of patients reaching various weight loss targets at different intervals
You should feel empowered to ask questions about your specific plan, including whether you need to pause Mounjaro before surgery, what to expect regarding blood sugar management, and when restart is appropriate

You cannot just skip to a completely different time without considering the gap between doses

This is useful for researchers who need finer dosing control but do not need the extreme dilution of lower concentrations